Abstract

The present disclosure relates to novel polymorph of Pirtobrutinib of formula-1 which is represented by the following structural formula-1 and process for preparation thereof.

Formula-1.

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

Share

COinS